Federal Contractor Profile
Ophirex, INC
$46M obligated·7 awards·1 agencies·3 NAICS
Federal Contracts
Showing contracts 1–19 of 19 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Mar 19, 2024 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH22C0030 | 541715 | FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY | $4.5M |
| Aug 22, 2023 | Department of DefenseARMY MED RES ACQ ACTIVITY | HT942523C0061 | 541715 | DHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510 | $1.3M |
| Jun 1, 2023 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH22C0030 | 541715 | FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY | $2.2M |
| Apr 7, 2023 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH22C0030 | 541715 | FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY | $2.9M |
| Jan 30, 2023 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $131K |
| Apr 5, 2022 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH22C0030 | 541715 | FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY | $14M |
| Feb 8, 2022 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $206K |
| Jul 28, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $1.6M |
| Apr 27, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0066 | 541715 | COVID-19 DHA 2018.1 SBIR PHASE III MEDICAL R&D CONTRACT PROPOSAL TITLED: "TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH SARS-COV-2" LOG #19000053 | $698K |
| Mar 31, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $958K |
| Mar 10, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH19C0082 | 541715 | DHA SBIR PH II MEDICAL R&D CONTRACT FOR PROPOSAL NO. H2-0440, TITLED: "BROAD SPECTRUM ENVENOMATION TREATMENT". | $550K |
| Nov 24, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $657K |
| Sep 1, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $2.3M |
| Jun 19, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0066 | 541715 | COVID-19 DHA 2018.1 SBIR PHASE III MEDICAL R&D CONTRACT PROPOSAL TITLED: "TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH SARS-COV-2" LOG #19000053 | $9.9M |
| Jun 1, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0017 | 541715 | ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE. | $3.6M |
| Jul 31, 2019 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH19C0082 | 541715 | DHA SBIR PH II MEDICAL R&D CONTRACT FOR PROPOSAL NO. H2-0440, TITLED: "BROAD SPECTRUM ENVENOMATION TREATMENT". | $975K |
| Jun 25, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH18C0144 | 541714 | DHA PHASE I SBIR PROPOSAL H181-002-0002, BROAD SPECTRUM ENVENOMATION TREATMENT | $149K |
| Apr 26, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH17C0069 | 541712 | IGF::OT::IGF SOCOM BAA AWARD PROPOSAL LOG SO150138 FIELD ANTIDOTE FOR SNAKE BITE | $449K |
| Apr 26, 2017 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH17C0069 | 541712 | IGF::OT::IGF SOCOM BAA AWARD PROPOSAL LOG SO150138 FIELD ANTIDOTE FOR SNAKE BITE | $177K |
Get Alerted Before Ophirex, INC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free